On this episode of NMOSD Master Class, Dr. Benjamin Greenberg from UT Southwestern, provides a critical review of the issues related to adjudicating relapses both in clinic and in clinical trials. Often the primary outcome of clinical trials in NMO is a relapse, but different definitions have been used over time. Additionally, in clinic it can be difficult to determine what clinical events constitute a relapse. Review the processes used to classify symptoms as new relapses or not is very important to both clinicians and researchers within the greater NMO community.
Benjamin Greenberg, MD
Associate Professor, Cain Denius Scholar in Mobility Disorders, Department of Neurology and Neurotherapeutics at UT Southwestern Medical Center.